221 related articles for article (PubMed ID: 16997137)
1. Chemogenomics: structuring the drug discovery process to gene families.
Harris CJ; Stevens AP
Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
[TBL] [Abstract][Full Text] [Related]
2. Compound library design for target families.
Balakin KV; Ivanenkov YA; Savchuk NP
Methods Mol Biol; 2009; 575():21-46. PubMed ID: 19727610
[TBL] [Abstract][Full Text] [Related]
3. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray.
Gagna CE; Lambert WC
Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979
[TBL] [Abstract][Full Text] [Related]
4. Doing more than just the structure-structural genomics in kinase drug discovery.
Marsden BD; Knapp S
Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.
Frye SV
Chem Biol; 1999 Jan; 6(1):R3-7. PubMed ID: 9889153
[TBL] [Abstract][Full Text] [Related]
6. Structure-based chemogenomics: analysis of protein family landscapes.
Pirard B
Methods Mol Biol; 2009; 575():281-96. PubMed ID: 19727620
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Chemogenomics: drug discovery's panacea?
Jacoby E
Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
[TBL] [Abstract][Full Text] [Related]
9. Chemogenomics approaches to novel target discovery.
Gaither LA
Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
[TBL] [Abstract][Full Text] [Related]
10. Selectivity assessment of kinase inhibitors: strategies and challenges.
Luo Y
Curr Opin Mol Ther; 2005 Jun; 7(3):251-5. PubMed ID: 15977423
[TBL] [Abstract][Full Text] [Related]
11. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
Alkhalfioui F; Magnin T; Wagner R
Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
[TBL] [Abstract][Full Text] [Related]
12. Structural diversity of G protein-coupled receptors and significance for drug discovery.
Lagerström MC; Schiöth HB
Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
14. A-kinase anchoring proteins: trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology.
Malbon CC
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):573-9. PubMed ID: 17786856
[TBL] [Abstract][Full Text] [Related]
15. Structural genomics and drug discovery: all in the family.
Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
[TBL] [Abstract][Full Text] [Related]
16. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
Presland J
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
[TBL] [Abstract][Full Text] [Related]
17. Modeling small molecule-compound binding to G-protein-coupled receptors.
Vaidehi N; Pease JE; Horuk R
Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
[TBL] [Abstract][Full Text] [Related]
18. [Advance in the research and discovery of novel drugs based on chemogenomics].
He BK; Ma ZC; Wang YG; Gao Y
Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023
[TBL] [Abstract][Full Text] [Related]
19. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.
Nidhi ; Glick M; Davies JW; Jenkins JL
J Chem Inf Model; 2006; 46(3):1124-33. PubMed ID: 16711732
[TBL] [Abstract][Full Text] [Related]
20. Structural genomics on membrane proteins: the MePNet approach.
Lundstrom K
Curr Opin Drug Discov Devel; 2004 May; 7(3):342-6. PubMed ID: 15216938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
